MGTCX
Price
$8.97
Change
-$0.01 (-0.11%)
Updated
Nov 13 closing price
RPTIX
Price
$112.99
Change
-$0.33 (-0.29%)
Updated
Nov 13 closing price
Ad is loading...

MGTCX vs RPTIX

Header iconMGTCX vs RPTIX Comparison
Open Charts MGTCX vs RPTIXBanner chart's image
Transamerica Mid Cap Growth C
Price$8.97
Change-$0.01 (-0.11%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$112.99
Change-$0.33 (-0.29%)
VolumeN/A
CapitalizationN/A
MGTCX vs RPTIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGTCX vs. RPTIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTCX is a Buy and RPTIX is a Buy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 32B vs. MGTCX (158M). RPTIX pays higher dividends than MGTCX: RPTIX (0.18) vs MGTCX (0.00). MGTCX was incepted earlier than RPTIX: MGTCX (11 years) vs RPTIX (9 years). MGTCX is a more actively managed with annual turnover of: 75.00 vs. RPTIX (21.70). MGTCX has a lower initial minimum investment than RPTIX: MGTCX (1000) vs RPTIX (500000). MGTCX annual gain was more profitable for investors over the last year : 34.03 vs. RPTIX (21.29). RPTIX return over 5 years is better than : 18.66 vs. MGTCX (-9.11).
MGTCXRPTIXMGTCX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years9 years-
Gain YTD17.23213.037132%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets158M32B0%
Annual Yield % from dividends0.000.18-
Returns for 1 year34.0321.29160%
Returns for 3 years-35.07-14.64240%
Returns for 5 years-9.1118.66-49%
Returns for 10 years-18.66N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNMD74.77-0.09
-0.12%
CONMED Corp
DOX92.71-0.15
-0.16%
Amdocs Limited
TERN7.17-0.29
-3.89%
Terns Pharmaceuticals
AUUD0.57-0.06
-8.93%
Auddia
EBS10.89-1.08
-9.02%
Emergent Biosolutions